-
Patient-Derived Gastric Cancer Assembloids: Modeling Tumor–S
2026-07-31
Shapira-Netanelov et al. introduce a gastric cancer assembloid model that integrates matched tumor organoids with patient-specific stromal cell subpopulations, closely replicating the cellular heterogeneity of primary tumors. This approach enables improved analysis of tumor–stroma interactions, drug response variability, and resistance mechanisms, supporting more physiologically relevant preclinical testing and personalized therapy development.
-
Cy5 Goat Anti-Rabbit IgG (H+L) Antibody: Precision in Advanc
2026-07-30
Explore how the Cy5 Goat Anti-Rabbit IgG (H+L) Antibody optimizes detection in immunological assays, with scientific insights into innate antiviral immunity. This article delivers technical depth, unique practical guidance, and a comparative view beyond standard fluorescence workflows.
-
Developmental SSRI Exposure Impairs Motivation via Mu Opioid
2026-07-30
This study demonstrates that developmental exposure to SSRIs, such as Fluoxetine HCl, leads to enduring motivational deficits in adolescent and adult mice. Notably, these deficits are specifically reversed by antagonism or knockdown of mu opioid receptors in the nucleus accumbens, illuminating a dissociation between serotonergic and opioid systems in reward processing and offering refined targets for depression research.
-
Nystatin (Fungicidin) for Candida Biofilm Disruption and Bey
2026-07-29
Explore the unique antifungal properties of Nystatin (Fungicidin) against Candida and Aspergillus species, with an emphasis on its impact on biofilm disruption and cellular adhesion. This article offers advanced, evidence-based insight distinct from standard guides.
-
CB-839 (Telaglenastat): Precision Targeting of Epitranscript
2026-07-29
Discover how CB-839 (Telaglenastat) enables advanced exploration of glutaminase-driven metabolic vulnerabilities in cancer, with new insights into epitranscriptomic regulation and practical assay optimization. This article reveals unique strategies for integrating CB-839 in translational research.
-
FOXO3-Mediated Dual Metabolic Inhibition in Hepatocellular C
2026-07-28
The reference study reveals how FOXO3 suppresses both glycolysis and glutaminolysis in hepatocellular carcinoma by directly repressing YAP transcription. This mechanistic insight proposes dual metabolic pathway inhibition as a promising strategy for metabolic-based HCC intervention.
-
Drimartol B Induces Apoptosis by Targeting AKT1-Glycolysis i
2026-07-28
This study identifies drimartol B, a sesquiterpene from Artemisia sphaerocephala, as a potent inducer of apoptosis in colorectal cancer cells. By suppressing the AKT1/GLUT1/HK2 pathway and disrupting glycolysis, drimartol B provides a mechanistic foundation for novel CRC therapies with reduced toxicity.
-
Octenidine Dihydrochloride: Membrane Mechanisms & Lab Innova
2026-07-27
Explore Octenidine dihydrochloride’s unique membrane-disruptive mechanism and its pivotal role as an antiseptic research compound. This article offers advanced scientific insights and practical assay guidance, setting it apart from existing reviews.
-
HRP Goat Anti-Mouse IgG (H+L) Antibody: Protocols & QC Guide
2026-07-27
The HRP Goat Anti-Mouse IgG (H+L) Antibody (SKU K1221) enables sensitive and specific detection of mouse primary antibodies in immunoassays such as Western blot, ELISA, IHC, and ICC. This reagent is best suited for workflows requiring reliable signal amplification using horseradish peroxidase conjugation. It should not be used for non-mouse primary antibodies or in protocols incompatible with HRP enzymatic detection systems.
-
WM-8014: Precision KAT6A Inhibitor for Senescence Workflows
2026-07-26
WM-8014 delivers unrivaled selectivity for KAT6A/B, empowering researchers to dissect epigenetic mechanisms of oncogene-induced senescence with high reproducibility and minimal cytotoxicity. This article details workflow enhancements, troubleshooting guidance, and actionable protocol parameters to elevate cancer biology research using this advanced inhibitor.
-
β-Amanitin in RNA Polymerase II Studies: Protocols & Innovat
2026-07-25
Harness β-Amanitin’s precise RNA polymerase II inhibition for unparalleled insight into transcriptional regulation and high-sensitivity toxin detection. This article bridges practical protocols, advanced assay design, and troubleshooting strategies, ensuring researchers leverage APExBIO’s β-Amanitin for robust results.
-
CCT007093: Applied Workflows for PPM1D Inhibitor Research
2026-07-24
CCT007093 enables precise modulation of the PPM1D signaling pathway, driving robust activation of P38 MAPK and facilitating mechanistic dissection of pyroptosis and selective cytotoxicity in disease models. Its DMSO-only solubility and pathway specificity make it a top choice for targeted pathway studies and translational research.
-
Ziprasidone Hydrochloride (A5350): Reliable Assays in Oncolo
2026-07-24
This article delivers a scenario-driven exploration of Ziprasidone Hydrochloride (SKU A5350), demonstrating its reliability in cell viability, proliferation, and cytotoxicity assays. Drawing on peer-reviewed data and real laboratory pain points, it provides actionable insights and protocol recommendations for biomedical researchers and lab technicians, with practical vendor comparisons and links to validated protocols.
-
Applied Workflows with Recombinant Human EGF in 3D Tumor Sph
2026-07-23
Leverage recombinant human EGF to enhance 3D glioblastoma spheroid assays and mucosal healing models. This guide delivers actionable workflows, troubleshooting insights, and experimental benchmarks, all grounded in high-purity APExBIO EGF for reproducible, translational results.
-
Sumatriptan Succinate: Metabolic Mechanisms and Research Des
2026-07-23
Explore the advanced metabolic pathways of Sumatriptan Succinate as a 5-HT1 receptor agonist, delving into enzyme-specific mechanisms and their impact on experimental strategies. This article uniquely bridges metabolic insight with practical guidance for migraine and inflammation research.